Skip to content

Clinical trials

Phase 3 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 3 Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20039
200414
200510
200631
200711
200813
20091
20107
201112
20129
20135
20146
20153
20164
20174
20182
20203
20212
20222
20231
20241
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149
Terminated14
Unknown status7
Not yet recruiting7
Active, not recruiting3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline56
Sanofi Pasteur, a Sanofi Company23
Merck Sharp & Dohme LLC15
Dynavax Technologies Corporation5
Gilead Sciences5
Henogen5
Bukwang Pharmaceutical4
VBI Vaccines Inc.4
Crucell Holland BV3
MCM Vaccines B.V.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B182
Diphtheria55
Tetanus54
Haemophilus Infections45
Whooping Cough41
Poliomyelitis35
Hepatitis B, Chronic18
HIV Infections8
Hepatitis8
Hepatitis A8

Trials

Showing 76 to 100 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.